Ironwood Pharmaceuticals, Inc. provided earnings guidance for the year 2022. For the year, the company expects total revenue to be in the range of $420 million to $430 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.11 USD | -0.12% | +2.92% | -29.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.11% | 1.29B | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2022